Geode Capital Management’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-241,991
Closed -$2.04M 4152
2015
Q4
$2.04M Buy
241,991
+2,194
+0.9% +$14.7K ﹤0.01% 2467
2015
Q3
$1M Buy
239,797
+50,401
+27% +$220K ﹤0.01% 2867
2015
Q2
$998K Buy
+189,396
New +$1.21M ﹤0.01% 2896

Geode Capital Management's OCAT Position: Q1 2016 in Review

Geode Capital Management sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q1 2016, closing a stake of 241,991 shares — an estimated $2.04M sold.

Geode Capital Management first reported a position in OCAT in Q2 2015 and held it in 3 quarters. The position peaked at $2.04M in Q4 2015. 1 fund tracked by Wall St. Rank holds OCAT as of Q1 2016.

  • Geode Capital Management reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q1 2016 after selling out during the quarter.
  • Geode Capital Management sold 241,991 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q1 2016, an estimated $2.04M.
  • Geode Capital Management first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q2 2015 and held it in 3 quarters.
  • Geode Capital Management's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $2.04M in Q4 2015.
  • 1 fund tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q1 2016.

Based on Geode Capital Management's 13F filing for Q1 2016, filed 13 May 2016.